Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers.
| Autor: | Manore, Sara1,2 (AUTHOR) manores2@winthropalumni.com, Zhuang, Chuling1,3 (AUTHOR) chuling.zhuang@uth.tmc.edu, Najjar, Mariana K.1,2,3 (AUTHOR) mariana.k.najjar@uth.tmc.edu, Wong, Grace L.1,2 (AUTHOR) glwong@houstonmethodist.org, Bindal, Shivani1 (AUTHOR) shivani.bindal@uth.tmc.edu, Watabe, Kounosuke4 (AUTHOR) kwatabe@wakehealth.edu, Lin, Jiayuh5 (AUTHOR) jlin@som.umaryland.edu, Lo, Hui-Wen1,2,3,4 (AUTHOR) hui-wen.lo@uth.tmc.edu |
|---|---|
| Zdroj: | Cells (2073-4409). Dec2024, Vol. 13 Issue 24, p2087. 25p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|